Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Leo Rafael Reif
AddedFeb 19, 2024
UpdatedMay 1, 2026
Leo Rafael Reif

Leo Rafael Reif

Board Member, Broad Institute

Leo Rafael Reif's Career

Broad Institute
Broad Institute

Cambridge, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Leo Rafael Reif's Career

Broad Institute
Broad Institute
NonprofitNonprofit$183.3M7502003Cambridge, MA, US
Board Member· Board

Recent news

What’s the real cost of chasing AGI? Power consolidation is just the start, says the AI Now Institute.TechCrunch · 2025
Who really benefits from the AI boom?Startups | TechCrunch · 2025
Neurode wants to treat and track ADHD symptoms through a wearable headbandTechCrunch · 2024

Leadership at Broad Institute

Phillip SharpPhillip SharpBoard Member
Louis V GerstnerLouis V GerstnerBoard Member
Eric LanderEric LanderBoard Member
BRIAN HSIAOYEH CHUBRIAN HSIAOYEH CHUBoard Member
Eric SchmidtEric SchmidtBoard Member
Mark NunnellyMark NunnellyBoard Member

Similar to Broad Institute

HudsonAlpha Institute for BiotechnologyHudsonAlpha Institute for BiotechnologyHuntsville, AL, USGenomic Medicine, Researchest. 2008HudsonAlpha Institute for BiotechnologyHuntsville, AL, US · est. 2008

HudsonAlpha: A US-based nonprofit advancing genomic medicine, research, and education.

Nonprofit · $2.3M225
New York Genome CenterNew York Genome CenterNew York City, NY, USGenomics Researchest. 2010New York Genome CenterNew York City, NY, US · est. 2010

New York Genome Center, Inc.: A noncommercial research organization, founded in 2010 in New York, US.

Nonprofit · $131M290
Innovative Genomics InstituteInnovative Genomics InstituteBerkeley, CA, USCrispr, Genome Editingest. 2014Innovative Genomics InstituteBerkeley, CA, US · est. 2014

IGI: Advancing genomic technology for improved health, sustainable agriculture, and a carbon-neutral economy.

Nonprofit · $11M118
MIT Koch Institute for Integrative Cancer ResearchMIT Koch Institute for Integrative Cancer ResearchCambridge, MA, USCancer Researchest. 2007MIT Koch Institute for Integrative Cancer ResearchCambridge, MA, US · est. 2007

MIT's Koch Institute: A leading US cancer research center, advancing integrative oncology studies.

Nonprofit · $6M221

Leo Rafael Reif's Similar Executives & Operators

James SlavetJames SlavetBoard Member · RedfinJulie BornsteinJulie BornsteinBoard Member · RedfinDavid LissyDavid LissyBoard Member · RedfinW Austin LigonW Austin LigonBoard Member · RedfinSelina TobaccowalaSelina TobaccowalaBoard Member · RedfinGlenn KelmanGlenn KelmanBoard Member · RedfinHoward W. LutnickHoward W. LutnickBoard Member · Newmark GroupBlake OklandBlake OklandBoard Member · Newmark Group

People Similar to Leo Rafael Reif

Sally KornbluthSally KornbluthPresident of the Massachusetts Institute of TechnologyWilliam Barton RogersWilliam Barton RogersPresident of the Massachusetts Institute of TechnologyL. Rafael ReifL. Rafael ReifFounder · MIT SolveKerry KelleyKerry KelleyPresident at Massachusetts Institute of Technology (MIT)Susan HockfieldSusan HockfieldBoard Member · PfizerCynthia BarnhartCynthia BarnhartChancellor of the Massachusetts Institute of Technology